Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update
Globe Newswire•27/10/2026•16:05 ET
0
Key Highlights
- ➤Ultragenyx will report third-quarter 2026 financial results November 3, 2026
- ➤Conference call begins at 5:00 p.m. ET on Tuesday, November 3
- ➤Webcast replay will remain available for three months
NOVATO, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Tuesday, November 3, 2026, to discuss its financial results and corporate update for the quarter ending September 30, 2026.
The live and replayed webcast of the call will be available through the company’s website at https://ir.ultragenyx.com/events-presentations. The replay of the call will be available for three months.
Get started
Create a free account to read the full story.